Literature DB >> 8526027

Compartmentalization within the common mucosal immune system.

Z Moldoveanu1, M W Russell, H Y Wu, W Q Huang, R W Compans, J Mestecky.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8526027     DOI： 10.1007/978-1-4615-1941-6_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  10 in total

1.  Generation of female genital tract antibody responses by local or central (common) mucosal immunization.

Authors:  H Y Wu; S Abdu; D Stinson; M W Russell
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Impairment by mucosal adjuvants and cross-reactivity with variant peptides of the mucosal immunity induced by injection of the fusion peptide PADRE-ELDKWA.

Authors:  Nipa Decroix; Perayot Pamonsinlapatham; Cahn P Quan; Jean-Pierre Bouvet
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

3.  Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans.

Authors:  A Kantele; M Häkkinen; Z Moldoveanu; A Lu; E Savilahti; R D Alvarez; S Michalek; J Mestecky
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 4.  Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system.

Authors:  H Y Wu; M W Russell
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

5.  Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes.

Authors:  L Musey; Y Ding; J Cao; J Lee; C Galloway; A Yuen; K R Jerome; M J McElrath
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.

Authors:  M W Russell; Z Moldoveanu; P L White; G J Sibert; J Mestecky; M Michalek S
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

Review 7.  From Concept to Clinical Product: A Brief History of the Novel Shigella Invaplex Vaccine's Refinement and Evolution.

Authors:  K Ross Turbyfill; Kristen A Clarkson; Edwin V Oaks; Robert W Kaminski
Journal:  Vaccines (Basel)       Date:  2022-04-01

8.  Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.

Authors:  J U Igietseme; I M Uriri; S N Kumar; G A Ananaba; O O Ojior; I A Momodu; D H Candal; C M Black
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 9.  Mucosal immunity and tolerance: relevance to vaccine development.

Authors:  C Czerkinsky; F Anjuere; J R McGhee; A George-Chandy; J Holmgren; M P Kieny; K Fujiyashi; J F Mestecky; V Pierrefite-Carle; C Rask; J B Sun
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

10.  Oral Vaccination Approaches for Anti-SHIV Immunity.

Authors:  Erandi Velarde de la Cruz; Lingyun Wang; Deepanwita Bose; Sailaja Gangadhara; Robert L Wilson; Rama R Amara; Pamela A Kozlowski; Anna Aldovini
Journal:  Front Immunol       Date:  2021-06-21       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.